Antioxidative effects of nonsteroidal anti-inflammatory drugs during the initiation stages of experimental colon carcinogenesis in rats

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 27, Issue 2, 2008, Pages 89-100

  Kanwar, Shailender S ^a   Vaiphei, Kim ^b   Nehru, Bimla ^a   Sanyal, Sankar N ^a  

^a PANJAB UNIVERSITY   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Antioxidative effects; Colon cancer; Dimethylhydrazine; Nonsteroidal anti inflammatory drugs

Indexed keywords

ACETYLSALICYLIC ACID; ALKALINE PHOSPHATASE; CATALASE; CELECOXIB; CITRULLINE; CYSTEINE; ETORICOXIB; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; NITRIC OXIDE SYNTHASE; SUPEROXIDE DISMUTASE;

ANTIOXIDANT ACTIVITY; ARTICLE; BRUSH BORDER; CHEMOPROPHYLAXIS; COLON CANCER; COLON CARCINOGENESIS; LIPID PEROXIDATION; MALE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT;

RATTUS;

EID: 45549098786     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/JEnvironPatholToxicolOncol.v27.i2.20     Document Type: Article

References (42)

1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Fever EJ, Thum MJ. Cancer Statistics, 2004. CA Cancer J Clin. 2004;54:8-29.
2. Singottuvelan M, Viswanathan P, Nalini N. Chemopreventive effect of trans-resveratrol- a phytoalexin against colonic aberrant crypt foci and cell proliferation in 1,2-dimethylhydrazine induced colon carcimogenesis. Carcinogenesis. 2006;27:1038-46.
3. Fiala ES. Investigation into the metabolism and mode of action of the colon carcinogen, 1,2-dimethylhydrazine and azoxymethane. Cancer. 1977;40:2436-45.
4. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? The Lancet. 2001;357:539-45.
5. Jaiswal M, LaRusso NF, Burgart LJ, Gores GJ. Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiosarcoma cells by a nitric oxide-dependent mechanism. Cancer Res. 2000;60:184-90.
6. Rigas B, Williams J. NO-releasing NSAIDs and colon cancer chemoprevention: A promising novel approach (Review). Int J Oncol. 2002;20:885-90.
7. Thun MJ, Namboodiri MM, Calle EE, Flandurs WD, Heath CW Jr. Aspirin use and risk of fatal cancer. Cancer Res. 1993;53:1322-7.
8. Hinz B, Brune K. Cyclooxygenase-2. 10 years later. J Pharmacol Expt Therap. 2002;300:367-75.
9. Steinbach G, Lynch PM, Phillips RKS, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunder B, Shen Y, Fujimura T, Su LK, Levin B. The effect of celecoxib, a cyclooxygenase-2 inhibitor in familial adenomatous polyposis. N Engl J Med. 2000;342:1946-52.
10. Kanwar SS, Vaiphei K, Nehru B, Sanyal SN. Chemopreventive effects of non-steroidal anti-inflammatory drugs on 1,2-dimethylhydrazine-induced colon carcinogenesis in rats. Toxicol Mech Meth. 2007;17:1-8.
11. Wiseman H, Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem J. 1996;313:17-29.
12. Kavihtala P, Kinnula V, Soini Y. Antioxidative response for nitric oxide production in breast carcinoma. Oncol Reports. 2004;12:755-9.
13. Haddad IY, Ischiropoulos H, Holm BA, Beckman JS, Baker JR, Matalon S. Mechanism of peroxynitrite-induced injury to pulmonary surfactants. Am J Physiol. 1993;265:555-64.
14. Radi R, Rodriguez M, Castrol L, Telleri R. Inhibition of mitochondrial electron transport by peroxynitrite. Arch Biochem Biophys. 1994;308:89-95.
15. Chazotte-Aubst L, Hainut P, Ohshima H. Nitric oxide nitrates tyrosine residues of tumor suppression p53 protein in MCF-7 cells. Biochem Biophys Res Commun. 2000;267:609-13.
16. Karithala P, Mantyniemi A, Kang SW, Kinnula VL, Soini Y. Peroxiredoxins in breast carcinoma. Clin Cancer Res. 2003;9:3418-24.
17. Brasitus TA, Dudeja PK, Dahiya R. Premalignant alterations in the lipid composition and fluidity of colonic brush membranes of rats administered 1,2-dimethylhydrazine. J Clin Invest. 1986;77:831-40.
18. Brasitus TA, Dudeja PK, Foster ES. 1,2-dimethylhydrazine-induced alterations in Na+/H+ exchange in rat colonic brush border membrane vesicles. Biochim Biophys Acta. 1988;938:483-8.
19. Stocks J, Dormandy TL. The auto-oxidation of human red cell lipids induced by hydrogen peroxide. Br J Haematol. 1971;20:95-111.
20. Kono Y. Generation of superoxide radical during autooxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys. 1978;186:189-95.
21. Luck H. Catalase. In: Bergmeyer, HU, editor. Methods of Enzymatic analysis. New York: Academic Press; 1971.
22. Moron MJ, Diperrie JW, Manher KB. Levels of glutathione, glutathione reductase and glutathiol-S-transferase by limited proteolysis. J Biol Chem. 1979;260:577-89.
23. Massey V, Williams Jr.CH. On the reaction mechanism of yeast glutathione reductase. J Biol Chem. 1965;240:4470-5.
24. Habig WH, Pabot MJ, Jakoby WS. Glutathione-S-transferase: the first enzymatic step in mercapturic acid formation. J Biol Chem. 1974;249:7130-9.
25. Stuehr DJ, Marletta MA. Synthesis of nitrite and nitrate in murine macrophage cell lines. Cancer Res. 1987;47:5590-4.
26. Boyde TR, Rahmatullah M. Optimization of conditions for the colorimetric determination of citrulline,using diacetyl monoxime. Anal Biochem. 1980;107:424-31.
27. Lees M, Paxman S. Modifications of Lowry's procedure for analysis of proteolipid proteins. Anal Biochem. 1972;47:184-92.
28. Davasana T, Menon VP, Rajasekhran KN. Prevention of 1,2- dimethylhydrazine-induced circulatory oxidative stress by bis-1,7- (2-hydroxyphenyl)-hepta-1,6-diene-3,5-diene during colon carcinogenesis. Pharmacol Reports. 2006;58:229-35.
29. Kuin K-S, Yoon J-H, Kim JK, Back SJ, Eling TE, Lee WJ, Ryu JH, Lee JG, Lee J-H, Yoo J-B. Cyclooxygenase inhibitors induce apoptosis in oral cavity cancer cells by increased expression of non-steroidal anti-inflammatory drug-activated gene. Biochem Biophys Res Comm. 2004;325:1298-303.
30. Cejas P, Casado E, Belda-Iniesta C, Castro JD, Espinosa E. Implications of oxidative stress and cell membrane lipid peroxidation in human cancer (Spain). Cancer Causes and Control. 2004;15:707-19.
31. Vladimiror YA. Free radicals, antioxidant enzymes and carcinogenesis. Free Radical Biol Med. 1990;8:583-99.
32. Caussens LM, Werb Z. Inflammation and Cancer. Nature. 2002;420:860-7.
33. Jarugan P, Olinski R. Activity of antioxidant enzymes in cancer disease. Postery Hig Med Dosw.1994;48:443-55.
34. Dimmeler S, Haendeler J, Nehls M, Zeiher A M. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1β-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J Exp Med. 1997;4:601-7.
35. Singh R, Pervin S, Karimi A, Cederbaum S, Chaudhari G. Arginase activity in human breast cancer cell lines: No-Hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells. Cancer Res. 2000;60:3305-12.
36. Mannick JB, Asano K, Izumi K, Kieff E, Stamler JS. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell. 1994;79:1137-46.
37. Genaro AM, Hortelano S, Alvarez A, Martinez C, Bosca L. Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels. J Clin Invest. 1995;95:1884-90.
38. Messmer UK, Ankarcrona M, Nicotera P, Brune B. p53 expression in nitric oxide-induced apoptosis. FEBS Lett. 1994;355:23-6.
39. Orrenius S, Thor H, Eklow L, Moldeus P, Jones DP, Compartmentation of detoxification reactions. In: Synder R, Parke DV, Kocsis JJ, Jollow DJ, Gibson GG, Eitmer CM, editors. Biological reactive intermediates. Part A. New York: Plenum Press; 1982.
40. Shijun Li, Tao Y, Yang JO, Oberley TD, Oberley LW. The role of cellular glutathione peroxidase redox regulation in the suppression of tumor cell growth by manganese superoxide dismutase. Cancer Res. 2000;60:3927-39.
41. Mates JM, Perez-Gomez C, Nunez-deCastro I. Antioxidant enzymes and human diseases. Clin Biochem. 1999;32:595-603.
42. Marnett LJ. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res. 1992; 52: 5575-89.